CorMedix Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-33.0M | $-24.6M | $-18.2M | $-20.5M | $-9.1M | $-3.4M | $-6.7M | $-10.9M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $36.9K | $25.6K | $15.1K | $15.1K | $5.2K | $7.0K | $12.2K | $12.2K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.7M | $1.3M | $3.2M | $2.2M | $1.3M | $274.4K | $692.4K | $1.2M |
| Net Cash from Operating Activities | $-28.6M | $-22.3M | $-12.5M | $-6.3M | $-3.6M | $-2.3M | $-6.3M | $-3.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $152.0K | $58.7K | $15.4K | $25.4K | $35.7K | $0 | $1.6K | $10.4K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $10.4M | $11.4M | $-23.6M | $-25.4K | $-35.7K | $0 | $-1.6K | $-10.4K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $20.5M | $7.1M | $43.6M | $8.4M | $5.2M | $1.1M | $0 | $10.5M |
| Net Change in Cash | $2.3M | $-3.8M | $7.5M | $2.0M | $1.5M | $-1.1M | $-6.3M | $6.8M |
| Free Cash Flow | $-28.7M | $-22.3M | $-12.5M | $-6.3M | $-3.7M | $-2.3M | $-6.3M | $-3.7M |